Friday, February 1, 2013

• GERON CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Fri, Feb 1)

Thursday, January 31, 2013

• 8 Stocks Under $10 Soaring Higherat TheStreet (Thu, Jan 31)

Monday, January 28, 2013

• Buy, Sell, or Hold: Peregrine Pharmaceuticalsat Motley Fool (Mon, Jan 28)

Friday, January 25, 2013

• Geron Corporation's Recent Catalystsat Seeking Alpha (Fri, Jan 25)

Monday, January 21, 2013

• 2 Speculative Cancer Playsat Seeking Alpha (Mon, Jan 21)

Friday, January 18, 2013

• 5 Stocks Ready to Break Outat TheStreet (Fri, Jan 18)

Thursday, January 17, 2013

• After-Hours Buzz: INTC, AXP & Moreat CNBC (Thu, Jan 17)

Friday, January 11, 2013

• The Most Interesting Thing at JPMorgan's Health Care Conferenceat Motley Fool (Fri, Jan 11)
• Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With CashMarketwired (Fri, Jan 11)

Thursday, January 10, 2013

• Geron's Update on Stem Cell AssetsZacks (Thu, Jan 10)

Tuesday, January 8, 2013

• GERON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Tue, Jan 8)

Monday, January 7, 2013

• BioTime acquires stem cell assets from Geron, raises $10 millionat bizjournals.com (Mon, Jan 7)
• BioTime signs definitive agreement with Geron regarding stem cell assetstheflyonthewall.com (Mon, Jan 7)
• GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial StaEDGAR Online (Mon, Jan 7)

Saturday, January 5, 2013

• Are Short-Sellers Onto Something at Peregrine?at Motley Fool (Sat, Jan 5)

Friday, January 4, 2013

• Fear of Heights Drags These Stocks Lowerat Motley Fool (Fri, Jan 4)

Wednesday, January 2, 2013

• CAPScall of the Week: Neuralstemat Motley Fool (Wed, Jan 2)
• Stem Cells, Dr. Oz And A Potentially Lucrative Investment Opportunityat Seeking Alpha (Wed, Jan 2)

Thursday, December 20, 2012

• Why Shares of Oncothyreon Imploded Yesterdayat Motley Fool (Thu, Dec 20)

Tuesday, December 18, 2012

• Cellular Dynamics to develop, sell products for GE Healthcareat bizjournals.com (Tue, Dec 18)
• Has Pharmacyclics Become the Perfect Stock?at Motley Fool (Tue, Dec 18)
• A Geron Update: Imetelstat Data, Restructuring, And The Road Aheadat Seeking Alpha (Tue, Dec 18)
• Stem Cell Technology To Revolutionize The Skin Care Industry?at Seeking Alpha (Tue, Dec 18)

Sunday, December 16, 2012

• Has Geron Become the Perfect Stock?at Motley Fool (Sun, Dec 16)

Wednesday, December 12, 2012

• 3 Hematology Successes Biotech Investors Need to Knowat Motley Fool (Wed, Dec 12)

Add GERN News to My Yahoo!